The MagMa Study: Quantum Magnetocardiography in Cardiomyopathy

Area of Science:

• Cardiology
• Medical Diagnostics
• Biophysics

Background:

• Cardiomyopathy (CM) diagnosis requires rapid screening tools.
• Magnetocardiography (MCG) showed promise in prior retrospective studies for CM detection.

Purpose of the Study:

• To prospectively assess the diagnostic accuracy of MCG as a screening method for suspected CM.
• To compare MCG performance against advanced imaging and endomyocardial biopsy.

Main Methods:

• 110 adult patients with suspected CM (post-coronary artery disease exclusion) and 220 healthy controls were enrolled.
• MCG, utilizing a superconducting quantum interference device, measured the heart's magnetic field.
• A T-beg-Tmax score (MCG score) was used to identify CM, with results compared to established diagnostic methods.

Main Results:

• MCG demonstrated high diagnostic accuracy: 94.74% sensitivity and 98.54% specificity.
• MCG correctly identified CM in cases where cardiac magnetic resonance imaging was inconclusive.
• Results were highly reproducible, with low statistical uncertainty (2.5%).

Conclusions:

• MCG provides a noninvasive, reproducible, and accurate method for rapid CM screening.
• MCG can efficiently direct patients towards advanced imaging, improving diagnostic workflows.
• The study supports MCG as a valuable tool for early detection of various cardiomyopathies.